Previous Close | 3.9100 |
Open | 4.0400 |
Bid | 3.9600 x 400 |
Ask | 4.0300 x 100 |
Day's Range | 3.8600 - 4.0784 |
52 Week Range | 3.2400 - 11.7500 |
Volume | |
Avg. Volume | 242,468 |
Market Cap | 143.857M |
Beta (5Y Monthly) | 0.09 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Q1 2024 scPharmaceuticals Inc Earnings Call
Despite a net loss and increased operational costs, scPharmaceuticals Inc (SCPH) reports significant progress in product development and market expansion.
scPharmaceuticals (SCPH) delivered earnings and revenue surprises of 20% and 6.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?